ByMyCell
ByMyCell is a biotechnology firm that offers metabolic engineering, synthetic biology, genomics, sequenciament, and bioinformatics services.
ByMyCell operates in bioinformatics, biopharma, biotechnology based in Latin America, founded in 2021.
Its activity falls under bioinformatics, biopharma, biotechnology; the profile below is assembled from public directory data.
The company is recorded as being based in Latin America.
Directory data places it at the Grant stage.
The company reports a headcount in the c_00011_00050 range.
It has disclosed roughly $1.1M in funding.
| Sector | Bioinformatics, Biopharma, Biotechnology |
|---|---|
| Headquarters | Latin America |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $1,100,000 |
Website: bymycell.com.br
Sign in to view the contact information we hold for ByMyCell.
Create a free account
Create a free account